All articles tagged: Post COVID-19 condition, unspecified (U09.9)
![]()
Evalytics
25 March at 05.38 AM
Marriage rates are up, and divorce rates are down, new data showsThe aftermath of Covid-19 lockdowns saw a surge in marriages in 2022, following a decline during the pandemic's onset. After decades of stability, marriage rates dropped to 5.1 per 1,000 people in 2020 but rebounded to 6.2 per capita by 2022, indicating a notable increase. The shift towards marriage was accompanied by reports of increased happiness among married individuals, suggesting a positive |
![]()
HealthDay
28 December at 05.13 PM
Few Children With SARS-CoV-2 Develop Post-COVID-19 ConditionFew children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop post-COVID-19 condition (PCC), according to a study published online Dec. 28 in JAMA Network Open.Frederick Dun-Dery, Ph.D., M.Phil., from the University of Calgary in Alberta, Canada, and colleagues quantified the prevalence of PCC among |
![]()
HealthDay
08 December at 04.54 PM
Radiological Society of North America, Nov. 26-30The annual meeting of the Radiological Society of North America was held from Nov. 26 to 30 in Chicago, drawing nearly 25,000 participants, including radiologists, radiation oncologists, physicists in medicine, radiologic technologists, and other health care professionals. The conference featured scientific papers from a number of subspecialtie |
![]()
HealthDay
27 November at 04.31 PM
COVID-19 Vaccination Before Infection Cuts Risk for Long COVIDCOVID-19 vaccination before infection is associated with a reduced risk for post-COVID-19-condition (PCC), according to a study published online Nov. 22 in The BMJ.Lisa Lundberg-Morris, from the University of Gothenburg in Sweden, and colleagues conducted a population-based cohort study to examine the effectiveness of primary COVID-19 v |
![]()
HealthDay
15 November at 04.37 PM
Preexisting Allergic Disease May Increase Risk for Long COVIDPreexisting asthma or rhinitis may increase the risk for long COVID (LC), according to a review published online Nov. 8 in Clinical & Experimental Allergy.Doreen Wolff, from the University of Magdeburg in Germany, and colleagues conducted a systematic literature review to examine the epidemiological evidence on allergic dise |
![]()
HealthDay
31 October at 03.44 PM
Paxlovid Not Helpful for Reducing Most Post-COVID-19 ConditionsOutpatient treatment of COVID-19 with nirmatrelvir-ritonavir (Paxlovid) reduces the risk for combined thromboembolic events, but does not affect the risk for other post-COVID-19 conditions (PCCs), according to a study published online Oct. 31 in the Annals of Internal Medicine.George N. Ioannou, B.M.B.Ch., from the University of Washin |
![]()
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
![]()
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
![]()
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
![]()
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |